Amgen Inc.Thousand Oaks, CA United States
Company Description
Amgen is among the biggest of the biotech big'uns, and it's determined to get even bigger. The company uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. Sales of Neulasta and Neupogen (both used as anti-infectives in cancer patients), Enbrel, for rheumatoid arthritis, and anti-anemia drugs Aranesp and Epogen together account for about 90% of the company's sales. Amgen has a healthy drug pipeline, as well as marketing alliances with Japanese brewer and drugmaker
| 1 Amgen Center Dr. | Phone: 805-447-1000 | http://www.amgen.com |
| Thousand Oaks, CA 91320 | Fax: 805-447-1010 | |
| United States |
Amgen Inc. Rankings
| #163 in FORTUNE 500 (May 2011) | S&P 500 | #156 in FT Global 500 (June 2011) |
Executives
| 394 executives listed for Amgen Inc.'s Thousand Oaks, CA location. | ||
| Chairman and CEO | Kevin Sharer | |
|---|---|---|
| President and COO | Robert Bradway | |
| EVP and CFO | Jonathan Peacock | |
Financials
| Company Type | Public - NASDAQ: AMGN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 17,800 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Amgen Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
